Document is current
Any future updates will be listed below
-
Authors
Angeloni, Miriam
Rizzi, Davide
Schoen, Simon
Caputo, Alessandro
Merolla, Francesco
Hartmann, Arndt
Ferrazzi, Fulvia
Fraggetta, Filippo
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TRR 305)
Bavarian Funding Programme for the Initiation of International Projects (BayIntAn_FAU_2024_19)
European Union—NextGenerationEU through the Italian Ministry of University and Research under PNRR—M4C2-I1.3 (3 Project PE_00000019 “HEAL ITALIA” CUP: B33C22001030006)
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 6 May 2025
First Online: 26 May 2025
Declarations
:
: Ethics approval was waived by ASP Catania internal technical commission (ref. CIG 876560888C), as this study was exclusively about developing and testing a framework. The patients’ slides are not publicly available, and the output of the algorithms was not used to make any clinical decisions on patients’ care.
: Not applicable.
: DR is full employee of TESI Group/GPI. AC, FM, and FiFr report ad hoc advisory board membership with Roche Diagnostics, Italia, unrelated to the current work. AH receives honoraria for lectures or consulting/advisory boards for Abbvie, Agilent, AstraZeneca, Biocartis, BMS, Boehringer Ingelheim, Cepheid, Diaceutics, Gilead, Illumina, Ipsen, Janssen, Lilly, Merck, MSD, Nanostring, Novartis, Pfizer, Qiagen, QUIP GmbH, Roche, Sanofi, 3DHistech and other research support from AstraZeneca, Biocartis, Cepheid, Gilead, Illumina, Janssen, Nanostring, Novartis, Owkin, Qiagen, QUIP GmbH, Roche, Sanofi. FiFr is one of the inventors of ‘Sample imaging and imagery archiving for imagery comparison Merlo, P.T. et al. US patent 16/688/613 2020’. The remaining authors have no conflicts of interest to declare.
